Recurrent wheezing (RW) has a significant impact on infants, caregivers, and society, but morbidity and related medical resource utilization (MRU) have not been thoroughly explored. The burden of RW needs to be documented with population-based data. The objective was to assess the characteristics, medical management, and MRU of RW infants identified from national claims data. Infants aged from 6 to 24 months, receiving 2 dispensations of respiratory drugs within 3 months, and presenting a marker of poor control (index date), were selected. During the 6 months after index date, MRU was described in the cohort and among 3 subgroups with more severe RW, defined as 4 dispensations of respiratory drugs, 3 dispensations of oral corticosteroids (OCS), or 1 hospitalization for respiratory symptoms.
BELHASSEN, M., DE BLIC, J., LAFOREST, L., LAIGLE, V., CHANUT-VOGEL, C. and DE POUVOURVILLE, G. (2016). Recurrent Wheezing in Infants. Medicine, 95(15).